XML 51 R37.htm IDEA: XBRL DOCUMENT v3.10.0.1
Noncash Share-based Compensation (Tables)
12 Months Ended
Dec. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Share-based Compensation Expense
Noncash share-based compensation expense is allocated to expense categories on the Consolidated Statements of Comprehensive Income (Loss). The following table summarizes noncash share-based compensation expense, net of amounts capitalized, for the years ended December 31, 2018, 2017 and 2016 (in thousands).
 
For the Year Ended December 31,
 
2018
 
2017
 
2016
Share-based compensation:
 
 
 
 
 
Cost of revenue
$
1,721

 
$
1,971

 
$
2,267

Operating expenses:
 
 
 
 
 
Selling and marketing
4,396

 
4,348

 
3,824

General and administrative
10,717

 
11,163

 
9,040

Research and development
4,619

 
5,314

 
5,335

Total included in operating expenses
19,732

 
20,825

 
18,199

Total share-based compensation expense
$
21,453

 
$
22,796

 
$
20,466

Share-based Compensation, Stock Options, Activity [Table Text Block]
The following table summarizes the Company’s stock option activity for the year ended December 31, 2018 (number of shares and intrinsic value in thousands):
 
Number of 
shares
under option
 
Weighted 
average
exercise price
 
Weighted 
average
remaining 
contractual
term (year)
 
Aggregate
intrinsic
value (1)
Outstanding, December 31, 2017
135

 
$
12.52

 
 
 
 
Granted

 

 
 
 
 
Exercised
(135)

 
12.52

 
 
 
 
Forfeited

 

 
 
 
 
Expired

 

 
 
 
 
Outstanding, December 31, 2018

 
$

 
0
 
$

Vested and exercisable at December 31, 2018

 
$

 
0
 
$

(1) The aggregate intrinsic value was calculated based on the positive difference between the estimated fair value of the Company’s common stock on December 31, 2018 of $31.40 and the grant date fair value.
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value [Table Text Block]
The following table summarizes the Company's SARs activity for the year ended December 31, 2018 (number of shares and intrinsic value in thousands):
 
Stock 
appreciation
rights
 
Weighted 
average
exercise price
 
Weighted 
average
remaining 
contractual
term (year)
 
Aggregate
intrinsic value 
(1)
Outstanding, December 31, 2017
356

 
$
10.97

 
 
 
 
Granted

 

 
 
 
 
Exercised
(69
)
 
11.17

 
 
 
 
Forfeited

 

 
 
 
 
Expired

 

 
 
 
 
Outstanding, December 31, 2018
287

 
$
10.92

 
1.86
 
$
5,869

Exercisable at December 31, 2018
287

 
$
10.92

 
1.86
 
$
5,869

Vested and expected to vest at December 31, 2018
287

 
$
10.92

 
1.86
 
$
5,869

(1) The aggregate intrinsic value was calculated based on the positive difference between the estimated fair value of the Company’s common stock on December 31, 2018 of $31.40 and the exercise price of the underlying SARs.
Schedule of Nonvested Performance-based Units Activity [Table Text Block]
The following table summarizes the Company's MSUs activity for the year ended December 31, 2018 (number of shares and intrinsic value in thousands):
 
Number of 
unvested awards
 
Weighted 
average
grant date fair value
 
Weighted 
average
remaining 
contractual
term (year)
 
Aggregate
intrinsic
value (1)
Unvested at December 31, 2017
387

 
$
23.48

 
 
 
 
Granted
117

 
38.18

 
 
 
 
Exercised
(85
)
 
31.83

 
 
 
 
Forfeited

 

 
 
 
 
Expired

 

 
 
 
 
Unvested at December 31, 2018
419

 
$
25.90

 
1.10
 
$
13,162

(1) The aggregate intrinsic value was calculated based on the positive difference between the estimated fair value of the Company’s common stock on December 31, 2018 of $31.40 and the grant date fair value of the underlying MSUs.
Fair value assumptions - market-based RSUs [Table Text Block]
The assumptions used to value the market-based RSUs granted in 2016 were as follows:
 
 
December 31, 2016
Volatility
 
44.98%
Risk-free interest rate
 
1.08%
Dividend yield
 

The fair value of the market-based RSUs is expensed over the derived service period for each separate vesting tranche. The derived service period for the vesting tranches of the market-based RSUs ranges between 1.01 and 1.98 years.
Market Stock Units Valuation Assumptions [Table Text Block]
Significant assumptions used in the Monte Carlo simulation model for MSUs granted during the years ended December 31, 2018, 2017 and 2016 are as follows:
 
For the Year Ended December 31,
 
2018
 
2017
 
2016
Volatility
43.67%
 
45.38%
 
44.06%
Risk-free interest rate
2.12%
 
1.56%
 
1.04%
Expected option life in years
2.97
 
3.07
 
2.93
Dividend yield
 
 

The assumptions related to fiscal year 2017 are presented on a weighted average basis for the various awards granted throughout the period.
Restricted Stock Unit - time based [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]
The following table summarizes the Company's unvested time-based RSUs as of December 31, 2018, and changes during the year then ended (number of shares and intrinsic value in thousands):
 
 
Number of
shares
 
Weighted 
average
grant date
fair value
 
Weighted 
average
remaining 
contractual
term (year)
 
Aggregate
intrinsic value 
(1)
Unvested at December 31, 2017
2,133

 
$
18.90

 
 
 
 
Granted
829

 
27.61

 
 
 
 
Vested
(792
)
 
20.49

 
 
 
 
Forfeited
(201
)
 
20.45

 
 
 
 
Unvested at December 31, 2018
1,969

 
$
21.77

 
2.02
 
$
61,827

Expected to vest at December 31, 2018
1,902

 
$
21.65

 
2.00
 
$
59,731

(1) The aggregate intrinsic value was calculated based on the fair value of the Company’s common stock on December 31, 2018 of $31.40.
Restricted stock unit - market-based [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]
The following table summarizes the Company's unvested market-based RSUs as of December 31, 2018, and changes during the year then ended (number of shares and intrinsic value in thousands):

 
Number of
shares
 
Weighted 
average
grant date
fair value
 
Weighted 
average
remaining 
contractual
term (year)
 
Aggregate
intrinsic value 
(1)
Unvested at December 31, 2017
345

 
$
10.86

 
 
 
 
Granted

 

 
 
 
 
Vested
(115
)
 
12.61

 
 
 
 
Forfeited
(15
)
 
9.98

 
 
 
 
Unvested at December 31, 2018
215

 
$
9.98

 
1.69
 
$
6,751

Expected to vest at December 31, 2018
211

 
$
9.98

 
1.69
 
$
6,611

(1) The aggregate intrinsic value was calculated based on the fair value of the Company’s common stock on December 31, 2018 of $31.40.